ARTICLE | Company News
Xtrana other research news
September 4, 2001 7:00 AM UTC
Xtrana received a $400,000 Phase I SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Center for Research Resources (NCRR) to develop nanofluidic compon...